FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Aristo Bio-Tech and Lifescience IPO and DHARNI Capital Services IPO.
Aristo Bio-Tech and Lifescience IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while DHARNI Capital Services IPO is a SME Fixed Price Issue proposed to list at BSE SME.
Aristo Bio-Tech and Lifescience IPO | DHARNI Capital Services IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Fixed Price Issue | Fixed Price Issue |
Listing At | NSE SME | BSE SME |
Lead Managers | Beeline Capital Advisors Pvt Ltd | Srujan Alpha Capital Advisors Llp |
Registrar | Link Intime India Private Ltd | Cameo Corporate Services Limited |
Market Maker | Sunflower Broking Private Limited | Sunflower Broking Private Limited |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Aristo Bio-Tech and Lifescience IPO is up to ₹13.05 Cr whereas the issue size of the DHARNI Capital Services IPO is up to ₹10.74 Cr. The final issue price of Aristo Bio-Tech and Lifescience IPO is ₹72.00 per share and of DHARNI Capital Services IPO is ₹20.00 per share.
Aristo Bio-Tech and Lifescience IPO | DHARNI Capital Services IPO | |
---|---|---|
Face Value | ₹10 per share | ₹1 per share |
Issue Price (Lower) | ||
Issue Price (Upper) | ||
Issue Price (Final) | ₹72.00 per share | ₹20.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 1600 shares | 6000 shares |
Fresh Issue Size | 18,12,800 shares | 53,70,000 shares |
Fresh Issue Size (Amount) | up to ₹13.05 Cr | up to ₹10.74 Cr |
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 18,12,800 shares | 53,70,000 shares |
Issue Size Total (Amount) | up to ₹13.05 Cr | up to ₹10.74 Cr |
Aristo Bio-Tech and Lifescience IPO opens on Jan 16, 2023, while DHARNI Capital Services IPO opens on Jan 18, 2023. The closing date of Aristo Bio-Tech and Lifescience IPO and DHARNI Capital Services IPO is Jan 19, 2023, and Jan 20, 2023, respectively.
Aristo Bio-Tech and Lifescience IPO | DHARNI Capital Services IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Jan 16, 2023 | Jan 18, 2023 |
Issue Close | Jan 19, 2023 | Jan 20, 2023 |
Basis Of Allotment (Tentative) | Jan 24, 2023 | Jan 25, 2023 |
Initiation of Refunds (Tentative) | Jan 25, 2023 | Jan 27, 2023 |
Credit of Share (Tentative) | Jan 27, 2023 | Jan 30, 2023 |
Listing date (Tentative) | Jan 30, 2023 | Jan 31, 2023 |
Anchor Lockin End date 1 | Feb 23, 2023 | Feb 24, 2023 |
Anchor Lockin End date 2 | Apr 24, 2023 | Apr 25, 2023 |
Aristo Bio-Tech and Lifescience IPO P/E ratio is 9.46, as compared to DHARNI Capital Services IPO P/E ratio of 34.48.
Aristo Bio-Tech and Lifescience IPO | DHARNI Capital Services IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100.00% | 100.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 73.37% | 73.64% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 9.46 | 34.48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹49.02 Cr. | ₹40.74 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Aristo Bio-Tech and Lifescience IPO retail investors (RII) are offered 8,60,800 shares while in DHARNI Capital Services IPO retail investors are offered 8,60,800 shares. Qualified institutional buyers (QIB) are offered in Aristo Bio-Tech and Lifescience IPO and in DHARNI Capital Services IPO.
Aristo Bio-Tech and Lifescience IPO | DHARNI Capital Services IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | 91,200 shares | 2,70,000 shares |
QIB | ||
NII | 8,60,800 shares | 25,50,000 shares |
RII | 8,60,800 shares | 25,50,000 shares |
Employee | ||
Others | ||
Total | 17,21,600 shares | 51,00,000 shares |
Aristo Bio-Tech and Lifescience IPO subscribed 217.72x in total, whereas DHARNI Capital Services IPO subscribed 6.57x.
Aristo Bio-Tech and Lifescience IPO | DHARNI Capital Services IPO | |
---|---|---|
QIB (times) | ||
NII (times) | 285.84x | 6.32x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 149.59x | 6.83x |
Employee (times) | ||
Other (times) | ||
Total (times) | 217.72x | 6.57x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|